Authors:
Lello, S
Monterubbianesi, M
Guardianelli, F
Bianchi, C
Simonelli, C
Citation: S. Lello et al., Clinical trial of a monophasic estroprogestin oral formulation containing 20 mu g ethinyl estradiol and 75 mu g gestodene, GYNECOL END, 15(4), 2001, pp. 265-271
Authors:
Caggiari, L
Zanussi, S
Bortolin, MT
D'Andrea, M
Nasti, G
Simonelli, C
Tirelli, U
De Paoli, P
Citation: L. Caggiari et al., Effects of therapy with highly active anti-retroviral therapy (HAART) and IL-2 on CD4(+) and CD8(+) lymphocyte apoptosis in HIV+ patients, CLIN EXP IM, 120(1), 2000, pp. 101-106
Authors:
Simonelli, C
Zanussi, S
Sandri, S
Comar, M
Lucenti, A
Talamini, R
Bortolin, MT
Giacca, M
De Paoli, P
Tirelli, U
Citation: C. Simonelli et al., Concomitant therapy with subcutaneous interleukin-2 and zidovudine plus didanosine in patients with early stage HIV infection, J ACQ IMM D, 20(1), 1999, pp. 20-27
Authors:
Zanussi, S
Simonelli, C
Bortolin, MT
D'Andrea, M
Comar, M
Tirelli, U
Giacca, M
De Paoli, P
Citation: S. Zanussi et al., Dynamics of provirus load and lymphocyte subsets after interleukin 2 treatment in HIV-infected patients, AIDS RES H, 15(2), 1999, pp. 97-103
Authors:
Zanussi, S
D'Andrea, M
Simonelli, C
Trabattoni, D
Bortolin, MT
Caggiari, L
Tirelli, U
Clerici, M
De Paoli, P
Citation: S. Zanussi et al., The effects of CD40 ligation on peripheral blood mononuclear cell interleukin-12 and interleukin-15 production and on monocyte CD14 surface antigen expression in human immunodeficiency virus-positive patients, SC J IMMUN, 49(3), 1999, pp. 286-292
Authors:
De Paoli, P
Zanussi, S
Caggiari, L
Bortolin, MT
D'Andrea, M
Simonelli, C
Tirelli, U
Citation: P. De Paoli et al., Kinetics of lymphokine production in HIV plus patients treated with highlyactive antiretroviral therapy and interleukin 2, J CLIN IMM, 19(5), 1999, pp. 317-325
Authors:
Zanussi, S
Simonelli, C
Bortolin, MT
D'Andrea, M
Crepaldi, C
Vaccher, E
Nasti, G
Politi, D
Barzan, L
Tirelli, U
De Paoli, P
Citation: S. Zanussi et al., Immunological changes in peripheral blood and in lymphoid tissue after treatment of HIV-infected subjects with highly active anti-retroviral therapy (HAART) or HAART+IL-2, CLIN EXP IM, 116(3), 1999, pp. 486-492